Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

The main symptom is lots of pus that keeps coming back during the day. They often need antibiotic eye drops, which need a prescription. Your doctor will decide. They are not harmful to vision. Until ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Return on investment - most recent fiscal year 16.16 ...

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Cipla is trading at Rs 1439.05, reflecting a 2.73% decrease today, while the one-week returns are at 1.6%. Cipla is currently priced at Rs 1434.00, indicating a 3.07% drop for today. The five-day ...

Cipla's stock is priced at Rs 1409.50, reflecting a decrease of 2.09% in today's trading session. Cipla is currently priced at Rs 1413.05, indicating a significant drop of 1.84% today. The 5-day ...

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the treatment of glaucoma.

After hours: February 3 at 4:10:51 PM EST Loading Chart for EYE ...